Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates

American Journal of Critical Care

Volumn 16, Issue 2, 2007, Pages 110-120

  Larson, Elaine L ^a,b   Quiros, Dave ^a   Giblin, Tara ^a   Lin, Susan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; ENTEROBACTER INFECTION; ENTEROCOCCUS; HAND WASHING; HEALTH PERSONNEL ATTITUDE; HOSPITAL; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; POLICY; PRACTICE GUIDELINE; QUESTIONNAIRE; STANDARD; STAPHYLOCOCCUS AUREUS; STATISTICAL MODEL; UNITED STATES;

ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; GUIDELINE ADHERENCE; HANDWASHING; HOSPITALS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LOGISTIC MODELS; ORGANIZATIONAL POLICY; PRACTICE GUIDELINES; QUESTIONNAIRES; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 34247857528     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Boyce JM. Consequences of inaction: importance of infection control practices. Clin Infect Dis. 2001;33(suppl 3):S133-S137.
2. Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med. 2005;33:1845-1853.
3. Trampuz A, Widmer AF. Hand hygiene: a frequently missed lifesaving opportunity during patient care. Mayo Clin Proc. 2004;79:109-116.
4. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance [published correction appears in Infect Control Hosp Epidemiol. 1995;16:498]. Infect Control Hosp Epidemiol. 1995;16:105-113.
5. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997; 25:584-599.
6. Critchley IA, Karlowsky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004;10:502-511.
7. Zoutman DE, Ford BD. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control. 2005;33:1-5.
8. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002; 51(RR-16):1-45.
9. Gaynes RP, Solomon S. Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv. 1996;22:457-467.
10. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282:1458-1465.
11. Cabana MD, Ebel BE, Cooper-Patrick L, Powe NR, Rubin HR, Rand CS. Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med. 2000;154:685-693.
12. Cabana MD, Rand CS, Becher OJ, Rubin HR. Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med. 2001;155:1057-1062.
13. Larson E. A tool to assess barriers to adherence to hand hygiene guideline. Am J Infect Control. 2004;32:48-51.
14. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-485.
15. Wilton P, Smith R, Coast J, Millar M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and costeffectiveness. J Health Serv Res Policy. 2002;7:111-117.
16. Farr BM. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis. 2004;17:317-322.
17. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24:362-386.
18. Vriens M, Blok H, Fluit A, Troelstra A, Van Der Werken C, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical center: a 10-year survey. Eur J Clin Microbiol Infect Dis. 2002;21:782-786.
19. Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005;11:457-465.
20. Wertheim HF, Vos MC, Boelens HA, et al. Low prevalence of methicillinresistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56:321-325.
21. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant enterococcus among inpatients at a university hospital. Clin Infect Dis. 2003;37:326-332.
22. Knox KL, Holmes AH. Regulation of antimicrobial prescribing practices: a strategy for controlling nosocomial antimicrobial resistance. Int J Infect Dis. 2002;6(suppl 1):S8-S13.
23. Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment. Infect Control Hosp Epidemiol. 2002;23:683-688.
24. Allegranzi B, Luzzati R, Luzzani A, et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unitacquired infections. J Hosp Infect. 2002;52:136-140.
25. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med. 2003;29:49-54.
26. Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect. 2003;53:177-182.
27. Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarr JJ, Raad II. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect. 2002;51:52-58.
28. Thomas C, Riley TV. Restriction of third generation cephalosporin use reduces the incidence of Clostridium difficile-associated diarrhoea in hospitalised patients. Commun Dis Intell. 2003;27(suppl):S28-S31.
29. Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis. 2002;15:395-400.
30. Bonten MJ. Prevention of infection in the intensive care unit. Curr Opin Crit Care. 2004;10:364-368.
31. Madaras-Kelly K. Optimizing antibiotic use in hospitals: the role of population- based antibiotic surveillance in limiting antibiotic resistance. Insights from the Society of Infectious Diseases pharmacists. Pharmacotherapy. 2003;23:1627-1633.
32. Moro ML, Petrosillo N, Gandin C. Antibiotic policies in Italian hospitals: still a lot to achieve. Microb Drug Resist. 2003;9:219-222.
33. Diekema DJ, Boots Miller BJ, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis. 2004;38:78-85.
34. The SENIC Project. Am J Infect Control. 1980;111(special issue):465-653.
35. Zoutman DE, Ford BD, Bryce E, et al. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control. 2003; 31:266-273.
36. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A.2005;102:3153-3158.
37. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2000;21:455-458.
38. Elliott P. Recognising the psychosocial issues involved in hand hygiene. J R Soc Health. 2003;123:88-94.
39. Larson EL, Aiello AE, Cimiotti JP. Assessing nurses' hand hygiene practices by direct observation or self-report. J Nurs Meas. 2004;12:77-85.
40. O'Boyle CA, Henly SJ, Larson E. Understanding adherence to hand hygiene recommendations: the theory of planned behavior. Am J Infect Control. 2001;29:352-360.
41. Pittet D. The Lowbury lecture: behaviour in infection control. J Hosp Infect. 2004;58:1-13.
42. Gould D. Systematic observation of hand decontamination. Nurs Stand. August 4-10, 2004;18:39-44.
43. Jumaa PA. Hand hygiene: simple and complex. Int J Infect Dis. 2005;9:3-14.
44. Stone PW, Clarke SP, Cimiotti J, Correa-de-Araujo R. Nurses' working conditions: implications for infectious disease. Emerg Infect Dis. 2004; 10:1984-1989.